A healthy debate: Navigating a changing investor relations landscape in the healthcare sector

A recent roundtable for investor relations professionals, hosted by IR magazine and Bloomberg, analyzed the complicated issues impacting healthcare investor relations' practices. Senior IR professionals from a range of healthcare and pharmaceutical companies, and leading sell-side analysts following the sector, discussed key macro and industry-specific issues affecting IR professionals in today's volatile marketplace.

Please complete the form below with the information requested. Once you have filled in the form, youwill be sent a link to the white paper to the email address you provide in the form.

We need this information so that we can make the white paper available to you, and so that we and Bloomberg can keep you updated via email and telephone of our products and services.

Neither IR Magazine nor Bloomberg will share this information with any third parties, and will only process it in accordance with our respective privacy policies, available here: IR Magazine privacy policy and Bloomberg privacy policy.

*Mandatory fields